Cost-effectiveness model to evaluate 200-day vs 100-day treatment with valganciclovir prophylaxis to reduce cytomegalovirus disease in high-risk (d-/r-) kidney transplant recipient in Spain
Services
Services
Date issued
2011Journal title
Value in Health
Type of content
Publicación de congreso
